NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C959. A total of 4 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,326,623 | +62.2% | 16,900 | +62.5% | 0.01% | +50.0% |
Q1 2024 | $1,434,368 | +8.9% | 10,400 | +4.0% | 0.01% | +100.0% |
Q4 2023 | $1,317,600 | +6.5% | 10,000 | -9.1% | 0.00% | -25.0% |
Q3 2023 | $1,237,500 | +236.5% | 11,000 | +182.1% | 0.00% | +300.0% |
Q2 2023 | $367,770 | -84.0% | 3,900 | -82.8% | 0.00% | -87.5% |
Q1 2023 | $2,297,694 | -16.1% | 22,700 | -12.0% | 0.01% | +60.0% |
Q3 2022 | $2,740,000 | -26.4% | 25,800 | -32.5% | 0.01% | -16.7% |
Q2 2022 | $3,724,000 | -60.5% | 38,200 | -62.0% | 0.01% | -33.3% |
Q1 2022 | $9,422,000 | +368.8% | 100,500 | +325.8% | 0.01% | +350.0% |
Q4 2021 | $2,010,000 | +302.8% | 23,600 | +353.8% | 0.00% | +100.0% |
Q3 2021 | $499,000 | -76.5% | 5,200 | -76.1% | 0.00% | -66.7% |
Q2 2021 | $2,122,000 | +251.9% | 21,800 | +251.6% | 0.00% | +200.0% |
Q1 2021 | $603,000 | -83.3% | 6,200 | -83.6% | 0.00% | -83.3% |
Q4 2020 | $3,614,000 | +322.2% | 37,700 | +323.6% | 0.01% | +100.0% |
Q3 2020 | $856,000 | -19.3% | 8,900 | +2.3% | 0.00% | -40.0% |
Q2 2020 | $1,061,000 | +21.4% | 8,700 | -13.9% | 0.01% | -28.6% |
Q1 2020 | $874,000 | -84.1% | 10,100 | -80.2% | 0.01% | -81.1% |
Q4 2019 | $5,493,000 | +231.3% | 51,100 | +177.7% | 0.04% | +184.6% |
Q3 2019 | $1,658,000 | +172.7% | 18,400 | +155.6% | 0.01% | +116.7% |
Q2 2019 | $608,000 | +138.4% | 7,200 | +148.3% | 0.01% | +100.0% |
Q1 2019 | $255,000 | -45.9% | 2,900 | -56.1% | 0.00% | -25.0% |
Q4 2018 | $471,000 | +27.6% | 6,600 | +120.0% | 0.00% | +33.3% |
Q3 2018 | $369,000 | -87.0% | 3,000 | -89.6% | 0.00% | -87.5% |
Q2 2018 | $2,829,000 | +34.3% | 28,800 | +13.4% | 0.02% | +14.3% |
Q1 2018 | $2,106,000 | -48.8% | 25,400 | -52.1% | 0.02% | -27.6% |
Q4 2017 | $4,112,000 | +4681.4% | 53,000 | +3685.7% | 0.03% | +2800.0% |
Q3 2017 | $86,000 | -77.2% | 1,400 | -82.9% | 0.00% | -75.0% |
Q2 2017 | $377,000 | -17.1% | 8,200 | -21.9% | 0.00% | -20.0% |
Q1 2017 | $455,000 | -79.1% | 10,500 | -81.3% | 0.01% | -76.2% |
Q4 2016 | $2,179,000 | +25.1% | 56,300 | +63.7% | 0.02% | +10.5% |
Q3 2016 | $1,742,000 | +10.5% | 34,400 | -0.9% | 0.02% | 0.0% |
Q2 2016 | $1,577,000 | +27.0% | 34,700 | +10.5% | 0.02% | +5.6% |
Q1 2016 | $1,242,000 | -63.8% | 31,400 | -48.2% | 0.02% | -56.1% |
Q4 2015 | $3,428,000 | -6.0% | 60,600 | -33.8% | 0.04% | -18.0% |
Q3 2015 | $3,645,000 | +56.1% | 91,600 | +87.3% | 0.05% | +51.5% |
Q2 2015 | $2,335,000 | -33.7% | 48,900 | -44.9% | 0.03% | -40.0% |
Q1 2015 | $3,522,000 | +22.3% | 88,700 | -31.2% | 0.06% | +27.9% |
Q4 2014 | $2,880,000 | +198.8% | 128,900 | +109.6% | 0.04% | +186.7% |
Q3 2014 | $964,000 | +36.2% | 61,500 | +28.9% | 0.02% | +36.4% |
Q2 2014 | $708,000 | +248.8% | 47,700 | +278.6% | 0.01% | +266.7% |
Q1 2014 | $203,000 | +13.4% | 12,600 | -34.4% | 0.00% | 0.0% |
Q4 2013 | $179,000 | -86.1% | 19,200 | -83.1% | 0.00% | -88.0% |
Q3 2013 | $1,285,000 | +182.4% | 113,500 | +233.8% | 0.02% | +127.3% |
Q2 2013 | $455,000 | – | 34,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,267 | $4,397,000 | 0.18% |
GROUP ONE TRADING, L.P. | 91,600 | $3,645,000 | 0.05% |
SIMPLEX TRADING, LLC | 143 | $122,000 | 0.01% |
Citadel Advisors | 74,100 | $2,948,000 | 0.00% |